Linked Life Data

7961542

Source:http://linkedlifedata.com/resource/pubmed/id/7961542

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1994-11-28
pubmed:abstractText
The goal of this paper is to increase the psychiatrist's awareness of issues and methods in pharmacoeconomics with the hope that this will lead to greater physician involvement in the ongoing cost-management debates. This paper will first examine the underlying dynamics of health economics as they relate to the treatment of major depressive disorder. It will then discuss cost-benefit factors in antidepressant pharmacotherapy with special focus on the economic implications of clinically relevant differences among antidepressant drug classes. The paper ends with a review of methods for the economic analysis of drug therapies and a discussion of research needs in this area.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0160-6689
pubmed:author
pubmed:issnType
Print
pubmed:volume
55 Suppl A
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
42-52; discussion 53-4, 98-100
pubmed:dateRevised
2005-11-16
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Pharmacoeconomic considerations when evaluating treatment options for major depressive disorder.
pubmed:affiliation
Department of Psychiatry, University of Kansas School of Medicine-Wichita 67214-3199.
pubmed:publicationType
Journal Article, Review